Citation: | HONG Jiahui, LIU Yongyang, FANG Yukun, QIU Yiyin, FANG Kai, CHEN Qingyong. CRP/ALB combined with lung consolidation in predicting the severity of COVID-19[J]. Chinese Journal of General Practice, 2024, 22(7): 1116-1120. doi: 10.16766/j.cnki.issn.1674-4152.003579 |
[1] |
QIN P, DU E Z, LUO W T, et al. Characteristics of the life cycle of Porcine Deltacoronavirus (PDCoV) in vitro: replication kinetics, cellular ultrastructure and virion morphology, and evidence of inducing autophagy[J]. Viruses, 2019, 11(5): 455. DOI: 10.3390/v11050455.
|
[2] |
WANG J, ZHU K, XUE Y, et al. Research progress in the treatment of complications and sequelae of COVID-19[J]. Front Med, 2021, 8: 757605. DOI: 10.3389/fmed.2021.757605.
|
[3] |
MACHHI J, HERSKOVITZ J, SENAN A M, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections[J]. J Neuroimmune Pharmacol, 2020, 15(3): 359-386. doi: 10.1007/s11481-020-09944-5
|
[4] |
ALPDAGTAS S, ILHAN E, UYSAL E, et al. Evaluation of current diagnostic methods for COVID-19[J]. APL Bioeng, 2020, 4(4): 041506. DOI: 10.1063/5.0021554.
|
[5] |
KERMALI M, KHALSA R K, PILLAI K, et al. The role of biomarkers in diagnosis of COVID-19: a systematic review[J]. Life Sci, 2020, 254: 117788. DOI: 10.1016/j.lfs.2020.117788.
|
[6] |
SCHNEIDER M. The role of biomarkers in hospitalized COVID-19 patients with systemic manifestations[J]. Biomark Insights, 2022, 17: 11772719221108909. DOI: 10.1177/11772719221108909.
|
[7] |
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中华临床感染病杂志, 2023, 16(1): 1-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYL202304001.htm
NATIONAL Health Commission of the PRC. Diagnosis and treatment plan for COVID-19 (trial version 10)[J]. Chinese Journal of Clinical Infectious Diseases, 2023, 16(1): 1-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYL202304001.htm
|
[8] |
SILVA D L, LIMA C M, MAGALHÀES V C R, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients[J]. J Hosp Infect, 2021, 113: 145-154. doi: 10.1016/j.jhin.2021.04.001
|
[9] |
BATTAGLINI D, LOPES-PACHECO M, CASTRO-FARIA-NETO H C, et al. Laboratory biomarkers for diagnosis and prognosis in COVID-19[J]. Front Immunol, 2022, 13: 857573. DOI: 10.3389/fimmu.2022.857573.
|
[10] |
MOLINS B, FIGUERAS-ROCA M, VALERO O, et al. C-reactive protein isoforms as prognostic markers of COVID-19 severity[J]. Front Immunol, 2023, 13: 1105343. DOI: 10.3389/fimmu.2022.1105343.
|
[11] |
LI J Y, LI M, ZHENG S S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19[J]. Biomark Med, 2020, 14(10): 827-837. doi: 10.2217/bmm-2020-0254
|
[12] |
师明明, 王雅杰. 血清PCT、ALB及D-D水平与新型冠状病毒肺炎患者病情严重程度间的相关性分析[J]. 标记免疫分析与临床, 2023, 30(6): 918-922. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202306004.htm
SHI M M, WANG Y J. A correlation analysis between serum PCT, ALB and D-D levels and disease severity in patients with novel coronavirus pneumonia[J]. Labeled Immunoassays and Clinical Medicine, 2023, 30(6): 918-922. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202306004.htm
|
[13] |
马旭灿, 丁颖威, 章炳文. 丙种球蛋白冲击治疗重症社区获得性肺炎的疗效及对患者血清免疫蛋白和淋巴细胞亚群的影响[J]. 中华全科医学, 2021, 19(9): 1497-1499, 1583. doi: 10.16766/j.cnki.issn.1674-4152.002095
MA X C, DING Y W, ZHANG B W. Effect of gamma globulin pulse therapy on patients with severe community-acquired pneumonia and on serum immune proteins and lymphocyte subsets[J]. Chinese Journal of General Practice, 2021, 19(9): 1497-1499, 1583. doi: 10.16766/j.cnki.issn.1674-4152.002095
|
[14] |
KARAKOYUN I, COLAK A, TURKEN M, et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients[J]. Int Immunopharmacol, 2021, 91: 107285. DOI: 10.1016/j.intimp.2020.107285.
|
[15] |
JOVIČIĆ B P, RAKOVIĆ I, GAVRILOVIĆ J, et al. Vitamin D, albumin, and D-dimer as significant prognostic markers in early hospitalization in patients with COVID-19[J]. J Clin Med, 2023, 12(8): 2825. DOI: 10.3390/jcm12082825.
|
[16] |
ZHANG C, ZHENG F X, WU X Y. Predictive value of C-reactive protein-to-albumin ratio for risk of 28-day mortality in patients with severe pneumonia[J]. J Lab Med, 2023, 47(3): 115-120. doi: 10.1515/labmed-2022-0114
|
[17] |
MALÉCOT N, CHRUSCIEL J, SANCHEZ S, et al. Chest CT characteristics are strongly predictive of mortality in patients with COVID-19 pneumonia: a multicentric cohort study[J]. Acad Radiol, 2022, 29(6): 851-860. doi: 10.1016/j.acra.2022.01.010
|